Serum PTTG3P was demonstrated to obtain a fine diagnostic accuracy in distinguishing HCC from LC patients, CHB patients, and healthy controls while the diagnostic potential of serum PTENP1 seems unsatisfactory. The gene discussed is PTENP1; the disease is laryngotracheoesophageal cleft.